Serum CTRP3 and RBP4 Levels in Obesity and Hypertension
NCT ID: NCT02226471
Last Updated: 2014-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2000 participants
OBSERVATIONAL
2012-03-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glypican4 and CTRP5 in Metabolic Syndrome and the Effect of Exercise on These Adipokines
NCT01688622
Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
NCT01372800
Leptin Biology in Adipose Tissue
NCT01800864
Optimized Cardioprotection Therapy in Obese Subjects With CAD
NCT04570527
Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure
NCT02812797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NW-NBP group
normal weight and blood pressure subjects
No interventions assigned to this group
NW-HTN group
Normal weight with hypertension subjects
No interventions assigned to this group
OB-NBP group
obese-normal blood pressure subjects
No interventions assigned to this group
OB-HTN group
Obese-hypertension subjects
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Obesity not taking anti-obese or lipid-lowering medications
Exclusion Criteria
2. pregnant or lactating
3. diabetes
4. thyroid disease
5. fractures
6. osteoporosis
7. tumors;
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Third Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deng Wu Quan
Chongqing southwest hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deng Wuquan, PHD
Role: STUDY_DIRECTOR
Southwest Hospital, China
References
Explore related publications, articles, or registry entries linked to this study.
Deng W, Li C, Zhang Y, Zhao J, Yang M, Tian M, Li L, Zheng Y, Chen B, Yang G. Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance. Diabetol Metab Syndr. 2015 Apr 10;7:33. doi: 10.1186/s13098-015-0029-0. eCollection 2015.
Related Links
Access external resources that provide additional context or updates about the study.
Implication of Progranulin and C1q/TNF-Related Protein-3 (CTRP3) on Inflammation and Atherosclerosis in Subjects with or without Metabolic Syndrome
Identification of Adipokine Clusters Related to Parameters of Fat Mass, Insulin Sensitivity and Inflammation
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SW1000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.